FindMyRecallSubscribe
Class II: temporary or reversible health riskCompleted

Zydus Pharmaceuticals (USA) Icosapent Ethyl Capsules 1 gram Recall

Icosapent Ethyl Capsules 1 gram, 120 Capsules per Bottle, Rx Only, Manufactured by Dopp…

Zydus Pharmaceuticals (USA) Inc · Pennington, NJ

Risk level
Class II
Reported by FDA
Jun 18, 2025
Recall ID
D-0497-2025
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals (USA) recalled Icosapent Ethyl Capsules 1 gram starting May 30, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0497-2025 on Jun 18, 2025. Reason: Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents. Status: Completed.

Why it was recalled

Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents.

Product description

Icosapent Ethyl Capsules 1 gram, 120 Capsules per Bottle, Rx Only, Manufactured by Doppel Farmaceutici s.r.l., Piacenza, Italy, Distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-7.

Lot numbers, UPCs & expiration codes

Lot #s: B237040, B237041, Exp 10/31/2025

Where it was sold

IL, PA, & MS

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0497-2025
Classification
Class II
Status
Completed
Recall initiated
May 30, 2025
FDA report date
Jun 18, 2025
Quantity
11,616 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals (USA) Inc

Original FDA data

Every field from FDA enforcement report D-0497-2025, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Completed
Country
United States
Event ID
96964
Address
73 Route 31 N
Code information
Lot #s: B237040, B237041, Exp 10/31/2025
Postal code
08534-3601
Report date
Jun 18, 2025
Product type
Drugs
Recall number
D-0497-2025
Classification
Class II
Recalling firm
Zydus Pharmaceuticals (USA) Inc
Product quantity
11,616 bottles
Reason for recall
Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Icosapent Ethyl Capsules 1 gram, 120 Capsules per Bottle, Rx Only, Manufactured by Doppel Farmaceutici s.r.l., Piacenza, Italy, Distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-7.
Distribution pattern
IL, PA, & MS
Recall initiation date
May 30, 2025
Initial firm notification
Letter
Center classification date
Jun 30, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0497-2025, published Jun 18, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls